Consultation for Utilization of the Panel
We provide free, medical education services to assist clinicians in better understanding the Autoimmune Brain Panel™ results. Please fill out the form below and we will contact you to set up a convenient time for you. Note: This service is open to healthcare providers only.
SHALL WE PUT SOMETHING BOTTOM OF PAGE?
(Bransfield R., et al. Healthcare. December 29, 2023)
A wide range of microbes—including bacteria, viruses, fungi, and parasites—have been associated with conditions such as autism spectrum disorder, schizophrenia, bipolar disorder, depression, anxiety, suicidality, and behavioral dysregulation, often through mechanisms involving neuroinflammation, immune activation, and altered gene expression.
(Breitschwerdt E., et al. Journal of Central Nervous System Disease. March 18, 2019)
An adolescent with severe, treatment-resistant psychosis for 18 months showed progressive improvement of neuropsychiatric symptoms, was able to discontinue psychiatric medications, and returned to pre-illness activities following combination antimicrobial therapy. He also experienced a resolution of Bartonella-associated skin lesions.
(Cross A., et al. Frontiers in Psychiatry. February 2, 2021)
A 7-year-old girl developed relapsing neuropsychiatric symptoms after travelling to a tick-endemic area. She tested positive for Lyme disease and multiple streptococcal infections, meeting PANDAS criteria. After 31 months of antimicrobial therapy and IVIg, she achieved complete remission and remained symptom-free at the time of publication.